Zdrowie i gospodarka · 03/03/2016

FDA Proposes New Requirements for Blood Lancets

The FDA is requiring manufacturers of blood lancets to submit a premarket approval application after reclassifying these devices from class I to class III, citing the need to reduce the risk of illness or injury associated with their use.